These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens. Barnes JL; Ketheesan N Immunol Cell Biol; 2007 Oct; 85(7):551-7. PubMed ID: 17563759 [TBL] [Abstract][Full Text] [Related]
10. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877 [TBL] [Abstract][Full Text] [Related]
11. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice. Su YC; Wan KL; Mohamed R; Nathan S Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831 [TBL] [Abstract][Full Text] [Related]
12. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Healey GD; Elvin SJ; Morton M; Williamson ED Infect Immun; 2005 Sep; 73(9):5945-51. PubMed ID: 16113315 [TBL] [Abstract][Full Text] [Related]
14. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents. Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960 [TBL] [Abstract][Full Text] [Related]
15. From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK. Gourlay LJ; Thomas RJ; Peri C; Conchillo-Solé O; Ferrer-Navarro M; Nithichanon A; Vila J; Daura X; Lertmemongkolchai G; Titball R; Colombo G; Bolognesi M FEBS J; 2015 Apr; 282(7):1319-33. PubMed ID: 25645451 [TBL] [Abstract][Full Text] [Related]
16. [The production of hybridomas producing monoclonal antibodies to the causative agent of melioidosis by using antigen-stimulated lymphocytes in an in-vitro system]. Titova NG; Razina IV; Sviridov VV; Iakovleva IV; Khrapova NP; Kulakov MIa Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):82-3. PubMed ID: 8553782 [No Abstract] [Full Text] [Related]
17. [Immunogenic potential of glanders and melioidosis agents]. Kalachev II; Baídus' AN; Ivanova OA; Ganina EA; Boldyrev IA; Svetoch EA Vestn Ross Akad Med Nauk; 1997; (6):32-7. PubMed ID: 9289277 [TBL] [Abstract][Full Text] [Related]
18. Immunoblot analysis to demonstrate antigenic variability of clinical isolated. Pseudomonas pseudomallei. Lertmemongkolchai G; Manmontri W; Leelayuwat C; Romphruk A; Waropastrakul S Asian Pac J Allergy Immunol; 1991 Jun; 9(1):5-8. PubMed ID: 1723272 [TBL] [Abstract][Full Text] [Related]
19. Killing of Pseudomonas pseudomallei by polymorphonuclear leukocytes and peritoneal macrophages from chicken, sheep, swine and rabbits. Markova N; Kussovski V; Radoucheva T Zentralbl Bakteriol; 1998 Jul; 288(1):103-10. PubMed ID: 9728410 [TBL] [Abstract][Full Text] [Related]
20. [The role of the surface antigens of Pseudomonas pseudomallei in the pathogenesis of melioidosis]. Piven' NN; Smirnova VI; Kapliev VI; Podzolkova GG; Khrapova NP Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):8-12. PubMed ID: 1724862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]